StockData
BioStem Technologies, Inc. logo

BioStem Technologies, Inc. (BSEM) stock

BSEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$0.64−0.07 (-10.23%)

Close on Nov 20, 2026Market cap $11.34MP/E –Yield –

BioStem Technologies shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

BioStem Technologies's shares outstanding was 17M at Jun 30, 2026.

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202617M–
Q2 FY2025Jun 30, 202523M–

More BioStem Technologies figures

See a number that looks wrong?